Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
2.
Science ; 369(6501):238-239, 2020.
Artículo | WHO COVID | ID: covidwho-705927
3.
Science ; 369(6501):238-239, 2020.
Artículo | WHO COVID | ID: covidwho-659687

RESUMEN

The article examines how Covid-19 pandemic is slowly mutating in the U S It mentions that sequencing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes helps researchers follow how the virus spreads;and cell culture experiments suggest that the mutation does not have the same benign effect in SARS-CoV-2 It mentions G614 variant causes a slight change in shape of spike, making it easier for protein to undergo structural changes according to Jeremy Luban

9.
Science ; 2020.
Artículo | WHO COVID | ID: covidwho-141443

RESUMEN

” On 20 April, the German Research Foundation announced it was awarding Drosten a one-off prize for “outstanding science communication during the COVID-19 pandemic (Leong survived his bout with SARS and is now treating COVID-19 patients himself His research interests were ideal preparation for COVID-19

12.
Science ; 2020.
Artículo | WHO COVID | ID: covidwho-57044

RESUMEN

The world is holding its breath After the novel coronavirus made its way from China around the world, one country after another adopted harsh measures to stop SARS-CoV-2 from spreading and overwhelming hospitals They have hit the pause button on their economies and their citizens’ lives, stopping sports events, religious services, and other social gatherings School closures in 188 countries affect more than 1 5 billion students Borders are closed and businesses shuttered While some countries are still seeing daily case numbers increase, others—first in Asia but increasingly in Europe—have managed to bend the curve, slowing the transmission of COVID-19

13.
Science ; 2020.
Artículo | WHO COVID | ID: covidwho-38277

RESUMEN

When malaria researcher Nicholas White saw coronavirus infections picking up around the world 2 months ago, he immediately thought of the impact they could have on poorer countries “In fragile health care systems, if you start knocking out a few nurses and doctors, the whole thing can collapse,” says White, who is based at Mahidol University in Bangkok “So we realized that the priority would be to protect them ” White and his colleagues at the Mahidol Oxford Tropical Medicine Research Unit wondered whether widely available drugs could help They have designed a trial in which 40,000 doctors and nurses in Asia, Africa, and Europe will prophylactically receive chloroquine or hydroxychloroquine, two old drugs against malaria White hopes the trial will start this month, but its launch has been “incredibly difficult because of bureaucratic processes,” he says

14.
Science ; 2020.
Artículo | WHO COVID | ID: covidwho-28022

RESUMEN

In another example of the blinding speed at which science is moving during the pandemic era, researchers at Aarhus University in Denmark will start a clinical trial of a drug named camostat mesylate tomorrow—barely 1 month after a Cell paper showed the compound can prevent the novel coronavirus, SARS-CoV-2, from entering human cells “If we are to have an impact on the rising epidemic, then we have to act right now,” says Ole Søgaard, the infectious disease physician leading the study

20.
Science ; 367(6481): 963-964, 2020 02 28.
Artículo en Inglés | MEDLINE | ID: covidwho-7134
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA